Anti-C1q antibodies as a specific serological marker In patients with active lupus nephritis

Serum Midkine Levels in Systemic Lupus Erythematosus

Serum level of Matrix metalloproteinase-9 in patients with systemic lupus erythematosus.

The Role of T-cell Immunoglobulin and Mucin Domain-Containing Molecule-3 as Disease Activity Marker in Systemic Lupus Erythematosus

Anti-C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis

Serum Homocysteine Levels and Microalbuminuria in Adult Patients with Systemic Lupus Erythematosus

Study of Some Biomarkers Changes in Patients with Lupus Nephritis and Their Correlation with Disease Activity and Progression

High-mobility group box 1, early activity marker in lupus nephritis

Urinary Soluble CD163 Levels as a Biomarker for Activity of Systemic Lupus Erythematosus

Serum and Circulatory Omentin mRNA Gene Expression as Predictive Markers of Systemic Lupus Erythematosus Disease Activity and Lupus Nephritis